Akcea Therapeutics, Inc.

Pharmaceutical company · Boston, Massachusetts, United States

Akcea Therapeutics, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $543 million sold in a notice filed in 2016.

Profile compiled from public records. Is this your company? Request a correction or update

Akcea Therapeutics at a glance

Typepharmaceutical company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2015
SEC industryPharmaceutical Preparations
SEC CIK1662524

What does Akcea Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $543.2 million sold (2016).

Frequently asked questions about Akcea Therapeutics

Where is Akcea Therapeutics headquartered?

Akcea Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

What does Akcea Therapeutics do?

Akcea Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

When was Akcea Therapeutics founded?

The earliest incorporation on record for Akcea Therapeutics, Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences